The pharma industry claims lower prescription drug prices will mean less access to new medication for Canadians. It’s an old threat that pits profits against patients’ rights to affordable drugs.
Academic rigor, journalistic flair
Articles on Prescription drugs
Displaying 1 - 20 of 65 articles
It is illegal to share prescription drugs with friends and family.
Prescription opiods, stimulants such as those used to treat ADHD and the ingredients found in sexual dysfunction drugs like Viagra are some of the drugs that are being marketed to US consumers.
About 1 in 4 Americans with diabetes who need insulin struggle to pay for this lifesaving drug.
Products aimed at sexual dysfunction and weight loss were the most common dietary supplements that contained hidden – and potentially harmful – ingredients.
Canada lags behind other developed countries in access to newer antimicrobials. Here’s why that matters, and what can be done about it.
Generic drug names are often long, but they can tell doctors what type of medicine it is and how it works. But it’s brand names that appear first and most prominently in Health Canada materials.
Tylenol has long been considered a go-to medication for low to moderate pain and for fever reduction, even during pregnancy. But mounting evidence suggests that it is unsafe for fetal development.
Energy drinks and coffee both contain lots of caffeine. That’s a problem for teens, especially those who take prescription stimulants.
Ending the opioid epidemic requires addressing not only treatment gaps in addiction and overdose, but also inadequate pain management.
Resistant bacteria aren’t the only risk posed by overprescribing antibiotics. A more immediate risk is side-effects and reactions, which a new review shows are surprisingly frequent and often severe.
From expanding children’s coverage to reducing surprise bills, Biden and lawmakers may be able to broaden health care access.
When news reports tout a drug, people get interested, even if the benefits are unproven. Patient hopes, requests and demands can easily turn into real prescriptions in their doctor’s office.
Studies repeatedly have shown that health care in general and the high cost of drugs in particular are among the top concerns of US voters. But with coronavirus, the issue may fade from prominence.
To implement pharmacare, the Liberals will need to negotiate with the provinces, and the mostly Conservative premiers are unlikely to make this easy. The insurance industry also has much to lose.
When codeine became a prescription only drug in 2018, the number of overdoses dropped, our new research shows. But restricting sales of codeine is only one way to reduce harm from opioids.
The 1964 report that paved the way for Canada’s medicare envisaged that after universal coverage for doctors, the next step would be prescription drugs. But that next step hasn’t come.
Drug companies have a job to do and so does Health Canada. When the relationship becomes murky, the public are at risk.
Three-quarters of people with an intellectual disability receive prescribed drugs.
The collective public health of Canada, the United States and Mexico will take a hit if the new NAFTA becomes law.
Top contributors
-
Professor Emeritus of Health Policy and Management, York University, Canada
-
Professor of Pharmacy Practice, University of Connecticut
-
Associate Professor of Public Health, Texas A&M University
-
Associate Professor, Political Science, McMaster University
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Conjoint Clinical Associate Professor, Deakin University School of Medicine and Specialist Pain Medicine Physician, Deakin University
-
Vice Chancellor’s Senior Research Fellow, Social and Global Studies Centre and Digital Ethnography Research Centre, RMIT University
-
Associate Professor in Public Health, La Trobe University
-
Senior research fellow, Monash University
-
Professor of Criminal Law, University of Sydney
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Honorary Fellow, Department of Health Sciences, University of York
-
Professor and Distinguished Research Chair, Globalization and Health Equity, L’Université d’Ottawa/University of Ottawa
-
Lecturer in Criminology, University of Auckland
-
Adjunct Associate Professor, School of Social Work, Columbia University
